HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Octreotide for treatment of postoperative chylothorax.

Abstract
Two infants who developed chylothorax after surgery for congenital heart disease were treated successfully with subcutaneous octreotide. Apart from reducing chyle output, octreotide decreased the triglyceride content of the pleural fluid.
AuthorsY Cheung, M P Leung, M Yip
JournalThe Journal of pediatrics (J Pediatr) Vol. 139 Issue 1 Pg. 157-9 (Jul 2001) ISSN: 0022-3476 [Print] United States
PMID11445812 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Hormones
  • Octreotide
Topics
  • Chylothorax (drug therapy)
  • Female
  • Heart Defects, Congenital (surgery)
  • Hormones (administration & dosage, therapeutic use)
  • Humans
  • Infant
  • Injections, Subcutaneous
  • Male
  • Octreotide (administration & dosage, therapeutic use)
  • Pleural Effusion (metabolism)
  • Postoperative Complications (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: